Can docetaxel combined prednisone effectively treat hormone refractory prostate cancer?

Medicine ◽

10.1097/md.0000000000020367 ◽

2020 ◽

Vol 99 (22) ◽

pp. e20367

Author(s):

Liang Cheng ◽

Cai-Fang Yue ◽

Yue Wang ◽

Hui-Feng Cao ◽

Jian-Feng Dong ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

147: Low Concentration of a Histone Deacetylase Inhibitor, Depsipeptide (FK228), Enhances the Effect of Gemcitabine and Docetaxel in Hormone Refractory Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)30412-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 50-51

Author(s):

Masatoshi Kanzaki ◽

Hideaki Kakinuma ◽

Teruaki Kumazawa ◽

Takamitsu Inoue ◽

Mitsuru Saito ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hormone Refractory Prostate Cancer ◽

Prostate Cancer Cells ◽

Low Concentration ◽

Deacetylase Inhibitor ◽

Hormone Refractory

Download Full-text

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)30844-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 202-202

Author(s):

Hirotsugu Uemura ◽

Motoyoshi Tanaka ◽

Shigeya Uejima ◽

Takafumi Minami ◽

Kiyohide Fujimoto ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

1014: Satraplatin Significantly Improves Progression Free Survival (PFS) and Pain Control in Patients with Advanced Hormone-Refractory Prostate Cancer (HRPC): Preliminary Results from the Phase III Sparc Trial

The Journal of Urology ◽

10.1016/s0022-5347(18)31242-4 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 335-335 ◽

Author(s):

Oliver Sartor ◽

Cora Sternberg ◽

J. Alfred Witjes ◽

Gurkamal Chatta ◽

David Vaughn ◽

...

Keyword(s):

Prostate Cancer ◽

Pain Control ◽

Progression Free Survival ◽

Phase Iii ◽

Hormone Refractory Prostate Cancer ◽

Free Survival ◽

Preliminary Results ◽

Hormone Refractory

Download Full-text

829: PSA-Flare up in Docetaxel Therapy of Hormone-Refractory Prostate cancer (HRPCA): Incidence and Clinical Impact?

The Journal of Urology ◽

10.1016/s0022-5347(18)34998-x ◽

2005 ◽

Vol 173 (4S) ◽

pp. 225-225

Author(s):

Peter Olbert ◽

Andres J. Schrader ◽

Axel Hegele ◽

Zoltan Varga ◽

Axel Heidenreich ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Impact ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

613: Sodium Selenate Inhibits the Progression of Hormone Refractory Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)37875-3 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 163-163

Author(s):

Niall M. Corcoran ◽

Anthony J. Costello

Keyword(s):

Prostate Cancer ◽

Sodium Selenate ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Development and Validation of LC-MS/MS Assays for GMC1, A Novel Hormone Refractory Prostate Cancer Molecule for Application to Pre-clinical Studies

10.26226/morressier.57d6b2b5d462b8028d88e627 ◽

2016 ◽

Author(s):

Oscar Ekpenyong

Keyword(s):

Prostate Cancer ◽

Clinical Studies ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Development And Validation

Download Full-text

Faculty Opinions recommendation of Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5261960.5203058 ◽

2010 ◽

Author(s):

Asad Umar

Keyword(s):

Prostate Cancer ◽

Predictive Factor ◽

Hormone Refractory Prostate Cancer ◽

Serum Mirna ◽

Hormone Refractory

Download Full-text

Faculty Opinions recommendation of Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718357928.793494166 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Phase Iii ◽

Hormone Refractory Prostate Cancer ◽

Phase Iii Trial ◽

Hormone Refractory

Download Full-text

Predictive Biomarkers of Response to Bc1-2 Biomodulation by G3139 and Docetaxel in Hormone-Refractory Prostate Cancer

10.21236/ada434488 ◽

2005 ◽

Author(s):

Anthony W. Tolcher

Keyword(s):

Prostate Cancer ◽

Predictive Biomarkers ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Androgen Replacement as Treatment for Hormone Refractory Prostate Cancer

10.21236/ada442980 ◽

2005 ◽

Author(s):

Walter M. Stadler

Keyword(s):

Prostate Cancer ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text